Comparative evaluation of thienopyridines on platelet aggregation in patients with ischemic heart disease in multi-centers in Okinawa
Not Applicable
- Conditions
- coronary heart disease
- Registration Number
- JPRN-UMIN000023489
- Lead Sponsor
- Graduate School of Medicine, University of Ryukyus Department of Cardiovascular Medicine, Nephrology and Neurology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 160
Inclusion Criteria
Not provided
Exclusion Criteria
1)Dialysis 2)Dangerously ill liver disease patient 3)Malignant tumor of the activity 4)The patient that art of planned coronary revasculalization is not completed 5)PCI enforcement patients within 7 days 6)Dangerously ill heart failure patient(LVEFless than 30%. NYHA IV) 7)More than less than 50,000 number of the platelets /micro l or 500,000 /micro l, it is less than 30% of hematocrit or more than 50% 8)Bleeding patient 9)Patients who need treatment with anticoagulant 10)The patient who is participating in other clinical trials 11)Pregnant patient 12)the patient who judged that the medical attendant was inappropriate
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method